A Triple Knowledge Lens[1] with its tripartite consideration of intellectual capital drivers namely—human capital, relationship capital and structural capital—provides a nuanced perspective on  pharmaceutical development. Human capital drivers suggest a role for the creative development and deployment of human capital within and outside organizational boundaries. Relationship capital drivers consider then the impact of network capital, cultural capital, and community capital on collaborative engagements between health innovation stakeholders. At a broader level, structural capital drivers provide a view to the requisite organizational and knowledge based capital as driving investments in intellectual capital development, open knowledge development and subsequently technology development to address disease burden.

[1] Amidon, D.M., Davis, Bryan Elliott. The Triple Knowledge Lens: Intangible Performance, IC Magazine (2006).